Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

@article{Warzocha1998PlasmaLO,
  title={Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.},
  author={Krzysztof Warzocha and Jacques Bienvenu and Patr{\'i}cia F. Rosas Ribeiro and Isabelle Moullet and Charles Dumontet and Eve-Marie Neidhardt-B{\'e}rard and Bertrand Coiffier and Gilles Salles},
  journal={British Journal of Cancer},
  year={1998},
  volume={77},
  pages={2357 - 2362}
}
A prospective study was performed to assess the use of plasma measurement of tumour necrosis factor (TNF), lymphotoxin alpha (LT alpha) and their soluble receptors (p55 and p75) for prognostic risk assignment in 61 patients with Hodgkin's disease. Plasma levels of TNF, p55 and p75, but not of LT alpha, were higher in Hodgkin's disease patients than in healthy controls. Plasma levels of TNF, p55 and p75 were associated with several prognostic factors for Hodgkin's disease, including those… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Nuclear factor - KBa pivotal transcription factor in chronic inflammatory diseases

  • PJ Bames, M Karin
  • N Eng J Med
  • 1997

Is there a rationale for high dose chemotherapy as first line treatment of advanced Hodgkin ' s disease ?

  • D Hasenclever, N Schimtz, V Diehl
  • Leuk Lymph
  • 1995
1 Excerpt

Similar Papers

Loading similar papers…